Tech Company Financing Transactions
KineMed Funding Round
KineMed closed a $15 million investment round on 8/6/2007. Investors included Stanford Financial Group and private investors.
Transaction Overview
Company Name
Announced On
8/6/2007
Transaction Type
Debt
Amount
$15,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
5980 Horton St. 470
Emeryville, CA 94608
USA
Emeryville, CA 94608
USA
Phone
Website
Email Address
Overview
KineMed, Inc. is a drug discovery and development company employing its proprietary translational medicine technology (AquaTag and KineMarker) to both identify active drug candidates preclinically and confirm their therapeutic activity and dose response in first-in-man studies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Fineman
Chief Scientific Officer
Marc Hellerstein
Browse more venture capital transactions:
Prev: 8/6/2007: Game Ready venture capital transaction
Next: 8/6/2007: BridgeLux venture capital transaction
Share this article
Where The Data Comes From
We do our best to record tech company VC transactions. VC transactions on this site are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs